Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

$0.04
+0.01 (+35.47%)
(As of 07/18/2024 ET)
Today's Range
$0.03
$0.05
50-Day Range
$0.03
$0.06
52-Week Range
$0.03
$1.00
Volume
2,520 shs
Average Volume
7,869 shs
Market Capitalization
$1.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

Nemaura Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6,446.2% Upside
$2.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.97
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.17 out of 5 stars

NMRD stock logo

About Nemaura Medical Stock (NASDAQ:NMRD)

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

NMRD Stock Price History

NMRD Stock News Headlines

Nemaura Medical Inc (NMRD)
NXNN Nexeon Medsystems Inc
49 wins… 3 losses… You do the math
The markets are chaotic right now… and yet, over the last year, my flagship strategy has issued a NEW trade every single week… All while maintaining a 49-3 win/loss record! How is that possible? It’s all thanks to a little move I call the “Tuesday Bear Trap…” See, when the markets open Tuesday, I use my proprietary trading tools AND my personal expertise, and I judge the direction of the overall market. Then, my flagship strategy finds a trade in the same direction on a trend stock… After that, it’s just a straightforward 2-step trade to target income week after week after week.
49 wins… 3 losses… You do the math
The markets are chaotic right now… and yet, over the last year, my flagship strategy has issued a NEW trade every single week… All while maintaining a 49-3 win/loss record! How is that possible? It’s all thanks to a little move I call the “Tuesday Bear Trap…” See, when the markets open Tuesday, I use my proprietary trading tools AND my personal expertise, and I judge the direction of the overall market. Then, my flagship strategy finds a trade in the same direction on a trend stock… After that, it’s just a straightforward 2-step trade to target income week after week after week.
Acutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2M
See More Headlines
Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
7/19/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
36
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.50
High Stock Price Target
$2.50
Low Stock Price Target
$2.50
Potential Upside/Downside
+6,446.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$80,000.00
Book Value
($0.41) per share

Miscellaneous

Free Float
24,042,000
Market Cap
$1.54 million
Optionable
No Data
Beta
-0.03
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Dewan Fazlul Hoque Chowdhury Ph.D. (Age 51)
    Chairman, Interim CFO, CEO, President and Principal Financial & Accounting Officer
    Comp: $338.58k
  • Dr. Arash Ghadar (Age 47)
    Chief Operating Officer
  • Mr. Jay L. Warner
    Head of U.S. Commercial Operations
  • Mr. Thomas Bendix Mortensen
    Head of E.U. Commercial Operations & Marketing
  • Ms. Samantha Sanders
    Global Head of Digital Programs

NMRD Stock Analysis - Frequently Asked Questions

How have NMRD shares performed this year?

Nemaura Medical's stock was trading at $0.2190 on January 1st, 2024. Since then, NMRD shares have decreased by 82.6% and is now trading at $0.0382.
View the best growth stocks for 2024 here
.

How were Nemaura Medical's earnings last quarter?

Nemaura Medical Inc. (NASDAQ:NMRD) released its earnings results on Monday, February, 12th. The company reported ($0.12) earnings per share for the quarter.

How do I buy shares of Nemaura Medical?

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NMRD) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners